Alectinib is a tyrosine kinase inhibitor that exerts its effects by selectively inhibiting the activities of anaplastic lymphoma kinase (ALK) and RET.
Authentic
Guarantee
Fast Delivery
Privacy Adverse Reactions of AlectinibAlectinib’s adverse reactions are based on clinical trial and post-marketing observations. Incidence rates are for refer···【Read More】
Update: 04 Mar,2026Source: Haiou HealthViews: 71
Main EfficacyAlectinib is indicated as monotherapy for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or me···【Read More】
Update: 04 Mar,2026Source: Haiou HealthViews: 74
Copyright2024@ BIGBEAR All right reserved BIGBEAR



